Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
718 participants
OBSERVATIONAL
2020-03-02
2026-05-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This includes characterization of:
* Patient demographics (eg, gender, age, and race)
* Patient baseline characteristics (eg, prior medications and procedures, medical history, asthma history, weight, height)
The secondary objectives of the study are:
* To characterize real-world use patterns of DUPIXENT® for asthma
* To assess the long-term effectiveness of DUPIXENT® in asthma patients in a real-world setting
* To assess effectiveness on comorbid type 2 inflammatory conditions in asthma patients treated with DUPIXENT®
* To collect long-term safety data on study participants in the real-world setting
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
NCT04550962
Study of REGN3500 and Dupilumab in Patients With Asthma
NCT03112577
Evaluation of Dupilumab's Effects on Airway Inflammation in Patients With Asthma
NCT02573233
Evaluation of Dupilumab in Patients With Severe Steroid Dependent Asthma
NCT02528214
A Study to Evaluate the Quality of Life in Male and Female Adult Participants With Severe Asthma Treated With Dupilumab in a Real-world Setting
NCT06018441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DUPIXENT®
There is no investigational product provided by the study sponsor and no therapeutic intervention regulated by this protocol. As a condition for eligibility, patients are required to initiate DUPIXENT® for asthma, according to the country-specific prescribing information, prescribed by their physician as part of their normal care (ie, not for the purpose of enrolling in the registry). Once patients enter the study, there are no protocol requirements regarding DUPIXENT® or any other treatments.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to understand and complete study-related questionnaires
* Provide signed informed consent; for patients under the age of 18, both parental (legal guardian) consent and patient assent are required
* Initiating treatment with DUPIXENT® for a primary indication of asthma according to the country-specific prescribing information
Exclusion Criteria
* Treatment with dupilumab within 6 months before the screening visit, or within 6 months of the baseline visit if the screening and baseline occur on the same day
* Any condition that, in the opinion of the investigator, may interfere with patient's ability to participate in the study or personal conditions and circumstances that can predictably prevent the patient from adequately completing the schedule of visits and assessments.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Management
Role: STUDY_DIRECTOR
Regeneron Pharmaceuticals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Research Center of Alabama, LLC
Birmingham, Alabama, United States
Arizona Allergy & Immunology Research
Gilbert, Arizona, United States
Medical Research of Arizona, a Division of Allergy, Asthma & Immunology Associates, Ltd.
Scottsdale, Arizona, United States
Children's Hospital of Orange County
Orange, California, United States
Riviera Allergy Medical Center
Redondo Beach, California, United States
Allergy & Asthma Medical Group and Research, A PC
San Diego, California, United States
Bensch Clinical Research, LLC
Stockton, California, United States
Allianz Research Institute, Inc.
Westminster, California, United States
Global Research Solutions
Hollywood, Florida, United States
Memorial Healthcare System
Hollywood, Florida, United States
Clinical Research Specialists, LLC
Kissimmee, Florida, United States
Kratz Allergy & Asthma
Port Richey, Florida, United States
GCP, Global Clinical Professionals
St. Petersburg, Florida, United States
Allergy & Asthma Diagnostic Treatment Center
Tallahassee, Florida, United States
Omni Allergy
Atlanta, Georgia, United States
Columbus Regional Research Institute
Columbus, Georgia, United States
IACT Health Southeast Lung Associates
Rincon, Georgia, United States
Treasure Valley Medical Research
Boise, Idaho, United States
Northwestern Medical Group Allergy & Immunology Clinic
Chicago, Illinois, United States
The University of Chicago
Chicago, Illinois, United States
NorthShore University Health System
Evanston, Illinois, United States
Asthma and Allergy Center of Chicago
Oak Park, Illinois, United States
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana, United States
Velocity Clinical Research
Overland Park, Kansas, United States
Dr. Henry J. Kanarek Allergy, Asthma & Immunology
Overland Park, Kansas, United States
Family Allergy and Asthma
Louisville, Kentucky, United States
Allergy & Asthma Specialists, PSC
Owensboro, Kentucky, United States
Schreiber Allergy
Rockville, Maryland, United States
Virgo-Carter Pediatrics
Silver Spring, Maryland, United States
Chesapeake Clinical Research, Inc.
White Marsh, Maryland, United States
University of Michigan Allergy Specialty Clinic and Food Allergy Clinic
Ann Arbor, Michigan, United States
University of Michigan
Ann Arbor, Michigan, United States
Allergy and Asthma Center of Minnesota
Maplewood, Minnesota, United States
Mayo Clinic
Rochester, Minnesota, United States
University of Mississippi Medical Center
Jackson, Mississippi, United States
ENT & Allergy Center of Missouri
Columbia, Missouri, United States
St. Louis Children's Hospital
St Louis, Missouri, United States
The Clinical Research Center, LLC
St Louis, Missouri, United States
Nebraska Medical Research Institute, Inc.
Bellevue, Nebraska, United States
CHI Health Clinic Pulmonary
Omaha, Nebraska, United States
Ocean Allergy & Respiratory Research Center
Brick, New Jersey, United States
Atlantic Research Center, LLC
Ocean City, New Jersey, United States
A Atat Progressive Pulmonary & Sleep Medicine
Brooklyn, New York, United States
New York Allergy and Sinus Centers
Glendale, New York, United States
Northwell Health Division of Allergy & Immunology
Great Neck, New York, United States
Northwell Health Physician Partners Pulmonary Medicine and Cardiology at Manhasset
Manhasset, New York, United States
NYU Langone Hospital - Long Island
Mineola, New York, United States
Summit Health
Oakland Gardens, New York, United States
RRH Allergy, Immunology & Rheumatology
Rochester, New York, United States
Allergy & Asthma Care of LI
Rockville Centre, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Allergy Partners of Western North Carolina
Asheville, North Carolina, United States
Allergy Partners of the Triangle
Cary, North Carolina, United States
UNC Children's Hospital
Chapel Hill, North Carolina, United States
Javara Inc. and Tryon Medical Partners, PLLC
Charlotte, North Carolina, United States
Airways Clinical Research Center
Winston-Salem, North Carolina, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Allergy, Asthma and Clinical Research Center
Oklahoma City, Oklahoma, United States
Oklahoma Institute of Allergy and Asthma Clinical Research, LLC
Oklahoma City, Oklahoma, United States
Portland Research
Happy Valley, Oregon, United States
Allergy and Asthma Specialists, P.C.
Blue Bell, Pennsylvania, United States
Columbo Asthma, Allergy and Immunology, LLC
Bryn Mawr, Pennsylvania, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Asthma, Nasal Disease & Allergy Research Center of New England
East Providence, Rhode Island, United States
National Allergy and Asthma Research, LLC
North Charleston, South Carolina, United States
Charleston ENT Associates, LLC
Summerville, South Carolina, United States
Precision Research Institute, LLC
Houston, Texas, United States
STAAMP Research, LLC
San Antonio, Texas, United States
Element Research Group
San Antonio, Texas, United States
Tanner Clinic
Layton, Utah, United States
Allergy Associates of Utah
Murray, Utah, United States
Seattle Allergy & Asthma Research Institute
Seattle, Washington, United States
Gundersen Health System
La Crosse, Wisconsin, United States
The University of British Columbia
Vancouver, British Columbia, Canada
St. Paul's Hospital
Vancouver, British Columbia, Canada
BLC Clinical Research
Burlington, Ontario, Canada
Evidence Based Medical Educator Inc.
Toronto, Ontario, Canada
Inspiration Research Limited
Toronto, Ontario, Canada
Dr. Syeed Anees Medicine Professional Corporation
Windsor, Ontario, Canada
Institut Universitaire de Cardiologie et de Pneumologie de Quebec (IUCPQ) - Universite Laval
Québec, , Canada
Sygehus Lillebaelt - Vejle Sygehus - Lungemedicinsk afdeling
Vejle, , Denmark
Centre Hospitalier du Pays d'Aix - Maladies Respiratoires
Aix-en-Provence, , France
CHU de Bordeaux
Bordeaux, , France
Centre Hospitalier Universitaire Dijon Bourgogne (CHU Dijon) - Hôpital Francois Mitterrand
Dijon, , France
Hôpital de la Croix-Rousse
Lyon, , France
Hôpital Nord
Marseille, , France
Hopital Jacques Monod
Montivilliers, , France
Fondazione Salvatore Maugeri
Bari, Apulia, Italy
Ospedale dei Bambini Vittore Buzzi ASST Fatebenefratelli Sacco
Milan, Lombardy, Italy
Ospedale Luigi Sacco, PU, ASST Fatebenefratelli Sacco
Milan, Lombardy, Italy
La Fondazione IRCCS Policlinico "San Matteo"
Pavia, Lombardy, Italy
Istituto Clinico Himanitas, Humanitas Mirasole S.p.a.
Rozzano, Lombardy, Italy
Azienda Sanitaria Locale Salerno
Battipaglia, Salerno, Italy
Istituto Nazionale di Riposo e Cura per Anziani
Ancona, The Marches, Italy
Hansaki Clinic
Kiyosu-shi, Aichi-ken, Japan
Hokkaido University Hospital
Kita-ku, Hokkaido, Japan
Kobe University Hospital
Kobe, Hyōgo, Japan
Dokkyo Medical University Hospital
Mibu, Tochigi, Japan
Juntendo University Hospital
Bunkyo-ku, Tokyo, Japan
Incorporated Medical Corporation, Shishin Iryokai, Respiratory Care Clinic Tokyo
Chuo-ku, Tokyo, Japan
Teikyo University Hospital
Itabashi-ku, Tokyo, Japan
Nihon University Itabashi Hospital
Itabashi-ku, Tokyo, Japan
Incorporated Medical Corporation, Jinyukai, Jinyu Clinic
Nakano Ku, Tokyo, Japan
Showa University Hospital
Shinagawa-ku, Tokyo, Japan
Tokyo Women's Medical University Hospital
Shinjuku-ku, Tokyo, Japan
The Fraternity Memorial Hospital
Sumida-ku, Tokyo, Japan
Agosto Allergy and Immunology
Cayey, , Puerto Rico
CardioPulmonary Research CSP
Guaynabo, , Puerto Rico
Instituto Pulmonary Diseases Torre Medica San Lucas
Ponce, , Puerto Rico
Rafael H Zaragoza - Urdaz
San Juan, , Puerto Rico
Fundacion de Investigacion de Diego
San Juan, , Puerto Rico
University of Puerto Rico Medical Sciences Campus
San Juan, , Puerto Rico
Hospital De La Santa Creu I Sant Pau
Barcelona, Catalonia, Spain
Hospital Universitari Vall d'Hebron
Barcelona, Catalonia, Spain
Hospital Germans Trias i Pujol
Barcelona, Catalonia, Spain
Complexo Hospialario Universitario A Coruña
A Coruña, Galicia, Spain
Fysikalisk Medicin
Lidingö, Stockholms Län [se-01], Sweden
Pennine Acute Hospitals NHS Trust
Manchester, Greater Manchester, United Kingdom
University Hospitals Birmingham NHS Foundation Trust
Birmingham, , United Kingdom
Royal Devon University Healthcare NHS Foundation Trust
Exeter, , United Kingdom
Gartnavel General Hospital
Glasgow, , United Kingdom
St. James Hospital Leeds
Leeds, , United Kingdom
Glenfield General Hospital
Leicester, , United Kingdom
St. Bartholomew's Hospital
London, , United Kingdom
Guy's Hospital
London, , United Kingdom
Wythenshawe Hospital
Manchester, , United Kingdom
Freeman Hospital
Newcastle upon Tyne, , United Kingdom
Nottingham University Hospitals NHS Trust
Nottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gall R, Jain N, Soong W, Settipane RA, Xia C, Zhang Y, Haselkorn T, Jacob-Nara JA, Siddiqui S. Dupilumab-Treated Patients with Asthma in the Real World: The RAPID Global Registry. Adv Ther. 2023 Mar;40(3):1292-1298. doi: 10.1007/s12325-022-02399-5. Epub 2023 Jan 10.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EUPAS41963
Identifier Type: OTHER
Identifier Source: secondary_id
R668-AS-1885
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.